Can cell death biomarkers predict the outcome of acute liver failure?

Liver International

Volumn 32, Issue 2, 2012, Pages 346-346

  Bantel, Heike ^a   Schulze Osthoff, Klaus ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CASPASE; CYTOKERATIN 18; EPITOPE; PARACETAMOL;

ACUTE LIVER FAILURE; APOPTOSIS; BILIRUBIN BLOOD LEVEL; CELL DEATH; COHORT ANALYSIS; HUMAN; LETTER; LIVER TOXICITY; LIVER TRANSPLANTATION; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PREDICTIVE VALUE; PROTEIN BLOOD LEVEL; PROTEIN CLEAVAGE; SCORING SYSTEM; SURVIVAL;

DRUG-INDUCED LIVER INJURY; FEMALE; HUMANS; LIVER; LIVER FAILURE, ACUTE; MALE;

EID: 84855560253     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2011.02636.x     Document Type: Letter

References (3)

1. Craig DG, Lee P, Pryde EA, Masterton GS, Hayes PC, Simpson KJ. Circulating apoptotic and necrotic cell death markers in patients with acute liver injury. Liver Int. 2011; 31: 1127-36.
2. Volkmann X, Anstaett M, Hadem J, et al. Caspase activation is associated with spontaneous recovery from acute liver failure. Hepatology 2008; 47: 1624-33.
3. Bechmann LP, Jochum C, Kocabayoglu P, et al. Cytokeratin 18-based modification of the MELD score improves prediction of spontaneous survival after acute liver injury. J Hepatol 2010; 53: 639-47.